A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)
Clinical trial NCT05632926 · COMPLETED
Trial details
- NCT number
- NCT05632926
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2023-05-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.